• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兄弟俩患常染色体隐性遗传的与ACTG2相关的内脏肌病

Autosomal Recessive ACTG2-Related Visceral Myopathy in Brothers.

作者信息

Mori Mari, Clause Amanda R, Truxal Kristen, Hagelstrom R Tanner, Manickam Kandamurugu, Kaler Stephen G, Prasad Vinay, Windster Jonathan, Alves Maria M, Di Lorenzo Carlo

机构信息

From the Division of Genetic and Genomic Medicine, Nationwide Children's Hospital, Columbus, OH.

Department of Pediatrics, The Ohio State University, Columbus, OH.

出版信息

JPGN Rep. 2022 Oct 20;3(4):e258. doi: 10.1097/PG9.0000000000000258. eCollection 2022 Nov.

DOI:10.1097/PG9.0000000000000258
PMID:37168481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10158422/
Abstract

UNLABELLED

Pediatric intestinal pseudo-obstruction (PIPO) is a heterogeneous condition characterized by impaired gastrointestinal propulsion, a broad clinical spectrum, and variable severity. Several molecular bases underlying primary PIPO have been identified, of which autosomal dominant ACTG2-related visceral myopathy is the most common in both familial or sporadic primary PIPO cases. We present a family with autosomal recessive ACTG2-related disease in which both parents have mild gastrointestinal symptoms and sons have severe PIPO and bladder dysfunction.

METHODS

Clinical genome sequencing was performed on the patients and the mother. Immunohistochemistry was performed on intestinal tissue from the patients to show expression levels of the .

RESULTS

Genome sequencing identified a 6.8 kb 2p13.1 loss that includes the gene and a maternally inherited missense variant p.Val10Met in the gene.

DISCUSSION

This case demonstrates that monoallelic hypomorphic variants may underly mild primary gastrointestinal symptoms, while biallelic mild variants can cause severe diseases. The Deletions of the noncoding exon can be an under-recognized cause of mild gastrointestinal symptoms unidentifiable by exome sequencing, explaining some instances of interfamilial variability with an apparent autosomal dominant inheritance. Genome sequencing is recommended as a genetic work-up for primary or idiopathic PIPO because of genetic heterogeneity.

摘要

未标记

小儿肠假性梗阻(PIPO)是一种异质性疾病,其特征为胃肠推进功能受损、临床谱广且严重程度各异。已确定了原发性PIPO的几种分子基础,其中常染色体显性ACTG2相关内脏肌病在家族性或散发性原发性PIPO病例中最为常见。我们报告了一个患有常染色体隐性ACTG2相关疾病的家族,其中父母均有轻度胃肠道症状,儿子患有严重的PIPO和膀胱功能障碍。

方法

对患者及其母亲进行临床基因组测序。对患者的肠道组织进行免疫组织化学检测以显示……的表达水平。

结果

基因组测序确定了一个6.8kb的2p13.1缺失,其中包括……基因以及该基因中一个母系遗传的错义变异p.Val10Met。

讨论

该病例表明,单等位基因低表达变异可能是轻度原发性胃肠道症状的基础,而双等位基因轻度变异可导致严重疾病。非编码外显子的缺失可能是外显子测序无法识别的轻度胃肠道症状的一个未被充分认识的原因,这解释了一些具有明显常染色体显性遗传的家族间变异性情况。由于遗传异质性,建议将基因组测序作为原发性或特发性PIPO的基因检查方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/10158422/7c925c6484d9/pg9-3-e258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/10158422/ffb5b0f3c484/pg9-3-e258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/10158422/7c925c6484d9/pg9-3-e258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/10158422/ffb5b0f3c484/pg9-3-e258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ceaa/10158422/7c925c6484d9/pg9-3-e258-g002.jpg

相似文献

1
Autosomal Recessive ACTG2-Related Visceral Myopathy in Brothers.兄弟俩患常染色体隐性遗传的与ACTG2相关的内脏肌病
JPGN Rep. 2022 Oct 20;3(4):e258. doi: 10.1097/PG9.0000000000000258. eCollection 2022 Nov.
2
Visceral Myopathy内脏肌病
3
Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.ACTG2基因中反复出现的精氨酸替代是内脏肌病疾病负担和严重程度的主要驱动因素。
Hum Mutat. 2020 Mar;41(3):641-654. doi: 10.1002/humu.23960. Epub 2019 Dec 19.
4
Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.ACTG2 中的变异是相当数量的澳大拉西亚原发性慢性肠假性梗阻患者的基础。
Neurogastroenterol Motil. 2018 Sep;30(9):e13371. doi: 10.1111/nmo.13371. Epub 2018 May 21.
5
Genome-wide analysis identifies MYH11 compound heterozygous variants leading to visceral myopathy corresponding to late-onset form of megacystis-microcolon-intestinal hypoperistalsis syndrome.全基因组分析鉴定出导致巨膀胱-小结肠-肠蠕动不良综合征晚发型的内脏肌病的 MYH11 复合杂合变异。
Mol Genet Genomics. 2024 Apr 16;299(1):44. doi: 10.1007/s00438-024-02136-3.
6
Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome.使用全基因组测序来确定包括梅干腹综合征在内的内脏肌病的遗传基础。
J Rare Dis (Berlin). 2023;2(1):9. doi: 10.1007/s44162-023-00012-z. Epub 2023 Jun 5.
7
Visceral myopathy diagnosed by a de novo mutation in a patient with chronic intestinal pseudo-obstruction-a case report.通过新发突变诊断的慢性假性肠梗阻患者的内脏肌病——病例报告
Transl Pediatr. 2021 Mar;10(3):679-685. doi: 10.21037/tp-20-316.
8
Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.新型 ACTG2 变异揭示了儿科慢性肠假性梗阻中的等位基因异质性和双等位基因遗传。
Clin Genet. 2021 Mar;99(3):430-436. doi: 10.1111/cge.13895. Epub 2020 Dec 14.
9
Expanding the genotypic spectrum of -related visceral myopathy.扩展 -相关内脏性肌病的基因型谱。
Cold Spring Harb Mol Case Stud. 2021 Jun 11;7(3). doi: 10.1101/mcs.a006085. Print 2021 Jun.
10
Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.肠平滑肌肌球蛋白γ-2 错义变异与常染色体显性家族性内脏肌病的分离。
Gastroenterology. 2012 Dec;143(6):1482-1491.e3. doi: 10.1053/j.gastro.2012.08.045. Epub 2012 Sep 6.

引用本文的文献

1
Megacystis-microcolon-intestinal hypoperistalsis syndrome: don't forget the bladder.巨膀胱-小肠细小运动不良综合征:别忽略了膀胱。
Pediatr Surg Int. 2024 May 7;40(1):124. doi: 10.1007/s00383-024-05711-2.

本文引用的文献

1
Expanding the genotypic spectrum of -related visceral myopathy.扩展 -相关内脏性肌病的基因型谱。
Cold Spring Harb Mol Case Stud. 2021 Jun 11;7(3). doi: 10.1101/mcs.a006085. Print 2021 Jun.
2
Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.新型 ACTG2 变异揭示了儿科慢性肠假性梗阻中的等位基因异质性和双等位基因遗传。
Clin Genet. 2021 Mar;99(3):430-436. doi: 10.1111/cge.13895. Epub 2020 Dec 14.
3
Pseudo-obstruction-inducing ACTG2R257C alters actin organization and function.
诱导假性肠梗阻的 ACTG2R257C 改变肌动蛋白的组织和功能。
JCI Insight. 2020 Aug 20;5(16):140604. doi: 10.1172/jci.insight.140604.
4
Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals.鉴定 15708 个人的 5'非翻译区变异的功能丧失影响。
Nat Commun. 2020 May 27;11(1):2523. doi: 10.1038/s41467-019-10717-9.
5
Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.ACTG2基因中反复出现的精氨酸替代是内脏肌病疾病负担和严重程度的主要驱动因素。
Hum Mutat. 2020 Mar;41(3):641-654. doi: 10.1002/humu.23960. Epub 2019 Dec 19.
6
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).《常染色体拷贝数变异解释和报告的技术标准:美国医学遗传学与基因组学学会(ACMG)与临床基因组资源(ClinGen)的联合共识推荐》
Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
7
Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.吡啶斯的明治疗小儿肠道假性梗阻:一名2岁女童的病例报告及文献综述
J Neurogastroenterol Motil. 2019 Oct 30;25(4):508-514. doi: 10.5056/jnm19078.
8
A mutation creating an upstream translation initiation codon in SLC22A5 5'UTR is a frequent cause of primary carnitine deficiency.SLC22A5 5'UTR 中产生的一个突变导致上游翻译起始密码子,是原发性肉碱缺乏症的常见病因。
Hum Mutat. 2019 Oct;40(10):1899-1904. doi: 10.1002/humu.23839. Epub 2019 Jul 3.
9
Oral Pyridostigmine-responsive Visceral Myopathy With ACTG2 Mutations: A Case Series.伴有ACTG2突变的口服吡啶斯的明反应性内脏肌病:病例系列
J Pediatr Gastroenterol Nutr. 2019 Jan;68(1):e16-e17. doi: 10.1097/MPG.0000000000002183.
10
Paediatric Intestinal Pseudo-obstruction: Evidence and Consensus-based Recommendations From an ESPGHAN-Led Expert Group.小儿肠假性梗阻:ESPEN 专家组的循证和共识推荐建议。
J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):991-1019. doi: 10.1097/MPG.0000000000001982.